Both OKI-005 and OKI-179 (class I, IIb, IV HDAC inhibitors) cause cell cycle arrest, apoptosis and growth inhibition in multiple murine and human B-cell lymphoma lines (Wang et al., 2019). The gene discussed is HDAC9; the disease is B-cell non-Hodgkin lymphoma.